Agape ATP (NASDAQ:ATPC) Issues Earnings Results

Agape ATP (NASDAQ:ATPCGet Free Report) announced its earnings results on Friday. The company reported $0.15 earnings per share for the quarter, FiscalAI reports. The firm had revenue of $0.01 million during the quarter. Agape ATP had a negative net margin of 125.89% and a negative return on equity of 8.43%.

Agape ATP Trading Down 0.4%

Shares of ATPC traded down $0.01 during mid-day trading on Friday, reaching $2.49. The company’s stock had a trading volume of 19,484 shares, compared to its average volume of 454,781. Agape ATP has a 1-year low of $1.72 and a 1-year high of $73.50. The business has a 50-day simple moving average of $2.82 and a two-hundred day simple moving average of $2.81. The stock has a market cap of $2.49 million, a P/E ratio of -1.87 and a beta of 0.38.

Institutional Investors Weigh In On Agape ATP

An institutional investor recently raised its position in Agape ATP stock. Citadel Advisors LLC boosted its stake in shares of Agape ATP Corporation (NASDAQ:ATPCFree Report) by 95.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 65,130 shares of the company’s stock after purchasing an additional 31,849 shares during the quarter. Citadel Advisors LLC owned about 0.13% of Agape ATP worth $82,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 0.01% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on ATPC. Wall Street Zen upgraded Agape ATP from a “sell” rating to a “hold” rating in a report on Monday, June 29th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Agape ATP in a report on Friday, May 22nd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Agape ATP presently has an average rating of “Sell”.

Read Our Latest Report on Agape ATP

Agape ATP Company Profile

(Get Free Report)

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.

Featured Stories

Earnings History for Agape ATP (NASDAQ:ATPC)

Receive News & Ratings for Agape ATP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agape ATP and related companies with MarketBeat.com's FREE daily email newsletter.